Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

Data from the Centers for Disease Control and Prevention released Tuesday shows meaningful declines in STI rates between 2022 ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

Sure, condoms are still an effective strategy for lowering the risk of sexually transmitted infections (STIs) — but now, they ...

ViiV Healthcare chief medical officer Harmony Garges said: “We know taking fewer medicines is an important consideration for ...

The centre specialises mainly in heroin addiction and in assisting drug users to be reincorporated into society. The site coordinator, Alfred Majara, spoke to the HERAUT regarding the new centre and .

Gammora was shown to be safe and effective in eliminating HIV-infected cells without harming surrounding uninfected cells, ...

for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets USP, 600 mg are indicated ...